Metabolomics paves the way for improved drug target identification
暂无分享,去创建一个
[1] U. Sauer,et al. High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins , 2022, Molecular systems biology.
[2] James H. Joly,et al. The landscape of metabolic pathway dependencies in cancer cell lines , 2020, bioRxiv.
[3] Chi Heem Wong,et al. Estimation of clinical trial success rates and related parameters , 2018, Biostatistics.
[4] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.
[5] A. González,et al. Nutrient sensing and TOR signaling in yeast and mammals , 2017, The EMBO journal.
[6] G. Drewes,et al. Tracking cancer drugs in living cells by thermal profiling of the proteome , 2014, Science.
[7] G. Siuzdak,et al. Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.
[8] Nicola Zamboni,et al. High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. , 2011, Analytical chemistry.
[9] Yudong D. He,et al. Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.